NYSEARCA:XLV

The Health Care Select Sector Spdr Fund ETF News

etoro logo Buy XLV
*Your capital is at risk
$152.18
+2.12 (+1.41%)
At Close: Jun 23, 2026

3 Biotech Stocks Set to Double by 2028

06:15am, Saturday, 20'th Apr 2024
Biotech stocks offer the possibility of groundbreaking medical advancements alongside the potential for explosive growth. While the sector carries inherent risks, a select group of biotech companies p
UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate on both earnings and revenues.
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
U.S. inflation jumped in March, surpassing expectations primarily due to higher petrol and shelter costs, dashing hopes of a June interest rate cut by the Fed.
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
The U.S. economy added 303, 000 jobs last month. That data breezed past expectations for 205, 000 job gains, according to FactSet consensus estimates, as quoted on CNBC.
Much chatter has been devoted to what's needed for the U.S. stock market rally to continue this year. A big one on the to-do list?
XLV tracks the 64 Health Care stocks in the S&P 500 Index. Its expense ratio is 0.10% and the ETF has over $40 billion in assets under management. With a 12% weighting in the S&P 500 Index, Health Car
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Health Care Select Sector SPDR ETF (XLV), a passively managed exchange traded fu
Capital markets appear content with playing the rate cut waiting game as the S&P 500 continues to rise to new highs. Meanwhile, renewed volatility could make investors reconsider adding an equal weigh

4 Best Sector ETFs to Play Now

03:01pm, Thursday, 14'th Mar 2024
In the ongoing bull market, tech stocks have mainly driven the rally. However, with the rally expanding over the last few months, indicating a significant enhancement in market breadth.

Why Biotech Stocks May Be Ready For A Recovery

03:59am, Saturday, 09'th Mar 2024
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stoc
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss his call for tech exhaustion ahead.

The 3 Hottest Healthcare ETFs to Buy in 2024

02:12pm, Monday, 26'th Feb 2024
Healthcare stocks started the year off very strongly as investors cheered the sector's advances. Among the sector's catalysts have been continued, strong enthusiasm for a new class of weight-loss drug
Health Care Select Sector SPDR Fund is recommended as a buy due to its strong mix of holdings, low expense ratio, and noteworthy dividend yield. XLV has outperformed its peer health care ETFs in terms
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE